From the Journals

Gender affirmation surgery has become more common

View on the News

Track outcomes to improve care

The study is thought provoking and suggests many areas for future study.

Gender-affirming surgery is the final step in a spectrum of treatments for gender identity disorders or transsexualism, including psychological counseling, hormonal therapies, and pubertal hormone blockers. Referrals for these treatments are increasing, and likely the demand for surgical treatment will also continue to increase.

A comprehensive database or other prospective tool to assess the comparative efficacy of these treatments, create quality metrics, and address long-term health or psychiatric outcomes should be pursued.

Future research must address cost effectiveness and cost burdens, given increased public funding for gender affirmation surgeries. Most longitudinal studies of patients who have undergone gender affirmation procedures have found high satisfaction rates with low rates of regret (less than 5%). However, when regret occurs, it can be surgically challenging and costly to reverse these procedures.

Marie Crandall , MD, is a professor of surgery at the University of Florida, Jacksonville. She made her comments in an editorial and had no industry disclosures (JAMA Surg. 2018 Feb 28. doi: 10.1001/jamasurg.2017.6232).


 

FROM JAMA SURGERY

The team identified 37,827 hospital encounters in the national database that had ICD-9 diagnosis codes of transsexualism or gender identity disorder that were listed in the National Inpatient Sample. The rate of those codes increased from 3.87/100,000 patients in 2000 to 14.22 /100,000 patients in 2014.

Mental health was the leading cause of hospitalization, accounting for 40.5% of admissions, a finding that “is consistent with the high prevalence of depression, anxiety, and suicidal ideation in this population,” the investigators said.

Patients were a median age of 38 years old; 57.1% identified as white; and 54.3% were categorized as male, 38.3% as female, and most of the rest as “inconsistent,” meaning their sex in the medical record did not match their procedures.

Almost 11% were hospitalized for gender affirmation surgery, including penile or vaginal construction. From 2000 to 2005, 72% of patients who underwent affirmation procedures had genital surgery; the number increased to 83.9% from 2006 to 2011. More than half of the patients weren’t covered by insurance, but the number covered by Medicare or Medicaid increased from 25 patients in 2012-2013 to 70 in 2014. Meanwhile, no one died in the hospital from gender reassignment surgery, and the median stay was 4 days.

Recommended Reading

Ulipristal acetate reduced bleeding for women with fibroids
MDedge Endocrinology
Are microRNAs the key to an endometriosis biomarker?
MDedge Endocrinology
Young female hematologic cancer survivors have increased infertility risk
MDedge Endocrinology
Teach your adolescent patients about normal menses, so they know when it’s abnormal
MDedge Endocrinology
Universal paternal Rh screening is cost effective in IVF
MDedge Endocrinology
Newer hormonal contraception formulations linked to breast cancer risk*
MDedge Endocrinology
Self-administered subcutaneous Depo-Provera ‘feasible and acceptable’
MDedge Endocrinology
Non-PCOS IVF: Two trials show no benefit with frozen embryo transfer
MDedge Endocrinology
Iodine deficiency linked to delay in pregnancy
MDedge Endocrinology
Gonadotropins succeed where clomifene fails
MDedge Endocrinology